...
search icon
ngne-img

Neurogene Inc, Common Stock

NGNE

NMQ

$18.42

-$0.35

(-1.86%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$273.62M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
102.08K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$14.42 L
$74.49 H
$18.42

About Neurogene Inc, Common Stock

Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNGNESectorS&P500
1-Week Return-9.97%-0.03%1.53%
1-Month Return2.96%4.56%4.75%
3-Month Return-53.01%1.29%2.77%
6-Month Return-45.13%-3.54%12.18%
1-Year Return-38.6%1.59%22.34%
3-Year Return-67.22%13.55%38.91%
5-Year Return-91.67%40.85%80.7%
10-Year Return-91.21%105.52%190.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue340.00K1.82M2.28M3.20M3.26M[{"date":"2019-12-31","value":10.42,"profit":true},{"date":"2020-12-31","value":55.82,"profit":true},{"date":"2021-12-31","value":69.8,"profit":true},{"date":"2022-12-31","value":97.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(340.00K)(1.82M)(2.28M)(3.20M)(3.26M)[{"date":"2019-12-31","value":-34000000,"profit":false},{"date":"2020-12-31","value":-182100000,"profit":false},{"date":"2021-12-31","value":-227700000,"profit":false},{"date":"2022-12-31","value":-319600000,"profit":false},{"date":"2023-12-31","value":-326200000,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses24.10M39.73M50.53M56.52M55.58M[{"date":"2019-12-31","value":42.65,"profit":true},{"date":"2020-12-31","value":70.3,"profit":true},{"date":"2021-12-31","value":89.41,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.35,"profit":true}]
Operating Income(24.44M)(41.55M)(50.53M)(56.52M)(55.58M)[{"date":"2019-12-31","value":-2444300000,"profit":false},{"date":"2020-12-31","value":-4155400000,"profit":false},{"date":"2021-12-31","value":-5053400000,"profit":false},{"date":"2022-12-31","value":-5651700000,"profit":false},{"date":"2023-12-31","value":-5558300000,"profit":false}]
Total Non-Operating Income/Expense--34.00K2.66M22.20M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.15,"profit":true},{"date":"2022-12-31","value":11.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(69.44M)(33.28M)(50.52M)(55.19M)(36.32M)[{"date":"2019-12-31","value":-6944200000,"profit":false},{"date":"2020-12-31","value":-3327700000,"profit":false},{"date":"2021-12-31","value":-5051700000,"profit":false},{"date":"2022-12-31","value":-5518900000,"profit":false},{"date":"2023-12-31","value":-3631700000,"profit":false}]
Income Taxes168.14K(1.00)17.00K(5.00K)(16.00K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":10.11,"profit":true},{"date":"2022-12-31","value":-2.97,"profit":false},{"date":"2023-12-31","value":-9.52,"profit":false}]
Income After Taxes--(50.53M)(55.18M)(36.30M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5053400000,"profit":false},{"date":"2022-12-31","value":-5518400000,"profit":false},{"date":"2023-12-31","value":-3630100000,"profit":false}]
Income From Continuous Operations--(50.52M)(55.19M)(36.32M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5051700000,"profit":false},{"date":"2022-12-31","value":-5518900000,"profit":false},{"date":"2023-12-31","value":-3631700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(69.44M)(33.28M)(50.52M)(55.19M)(36.32M)[{"date":"2019-12-31","value":-6944200000,"profit":false},{"date":"2020-12-31","value":-3327700000,"profit":false},{"date":"2021-12-31","value":-5051700000,"profit":false},{"date":"2022-12-31","value":-5518900000,"profit":false},{"date":"2023-12-31","value":-3631700000,"profit":false}]
EPS (Diluted)(2.67)(0.64)(1.10)(1.04)(2.22)[{"date":"2019-12-31","value":-267,"profit":false},{"date":"2020-12-31","value":-64,"profit":false},{"date":"2021-12-31","value":-110,"profit":false},{"date":"2022-12-31","value":-104,"profit":false},{"date":"2023-12-31","value":-221.77,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NGNE
Cash Ratio 8.80
Current Ratio 9.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NGNE
ROA (LTM) -32.36%
ROE (LTM) -41.34%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NGNE
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NGNE
Trailing PE NM
Forward PE NM
P/S (TTM) 301.43
P/B 2.03
Price/FCF NM
EV/R 166.88
EV/Ebitda NM

FAQs

What is Neurogene Inc share price today?

Neurogene Inc (NGNE) share price today is $18.42

Can Indians buy Neurogene Inc shares?

Yes, Indians can buy shares of Neurogene Inc (NGNE) on Vested. To buy Neurogene Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NGNE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Neurogene Inc be purchased?

Yes, you can purchase fractional shares of Neurogene Inc (NGNE) via the Vested app. You can start investing in Neurogene Inc (NGNE) with a minimum investment of $1.

How to invest in Neurogene Inc shares from India?

You can invest in shares of Neurogene Inc (NGNE) via Vested in three simple steps:

  • Click on Sign Up or Invest in NGNE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Neurogene Inc shares
What is Neurogene Inc 52-week high and low stock price?

The 52-week high price of Neurogene Inc (NGNE) is $74.49. The 52-week low price of Neurogene Inc (NGNE) is $14.42.

What is Neurogene Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Neurogene Inc (NGNE) is 2.03

What is the Market Cap of Neurogene Inc?

The market capitalization of Neurogene Inc (NGNE) is $273.62M

What is Neurogene Inc’s stock symbol?

The stock symbol (or ticker) of Neurogene Inc is NGNE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top